prostate cancer

Lantheus taps GE HealthCare to sell its PSMA PET tracer in Japan

Lantheus gave GE HealthCare the rights to its Pylarify prostate cancer imaging agent in Japan, which plans to lean on its Nihon Medi-Physics division.

Conor Hale Sep 24, 2025 11:30am

A series of dice with a bag on them illustrating cost cuts

Oric lays off 20% of workforce in focus on clinical-stage drugs

Aug 13, 2025 6:20am

Paint brushes sitting on a colorful canvas

Radiopharma biotech Artbio paints path to clinic with $132M

Jul 29, 2025 7:30am

MA strategy deal block push come together form

Research non-profit acquires embattled Essa in Xoma-backed deal

Jul 14, 2025 9:30am

Micrograph showing the most common prostate cancer

Nuclidium raises $99M for copper-based radiopharma pipeline

Jul 10, 2025 5:04am

White arrow on a road pointing to the rising sun

J&J shares survival data on KLK2 bispecific in prostate cancer

Jun 2, 2025 6:40am